DGAT1 and neuroblastoma: Hence, in this study, the mouse neuroblastoma cell line N2a was treated with DGAT inhibitors DGAT1i (A922500, 10 μg/ml), DGAT2i (PF06424439, 60 μg/ml) or DGAT1i + DGAT2i (A922500+PF06424439, 10 μg/ml+60 μg/ml), and then infected with RABV or EMCV.